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ABSTRACT
The Cervical Cancer gene DataBase (CCDB, http://
crdd.osdd.net/raghava/ccdb) is a manually curated
catalog of experimentally validated genes that are
thought, or are known to be involved in the different
stages of cervical carcinogenesis. In spite of the
large women population that is presently affected
from this malignancy still at present, no database
exists that catalogs information on genes
associated with cervical cancer. Therefore, we
have compiled 537 genes in CCDB that are linked
with cervical cancer causation processes such as
methylation, gene amplification, mutation, poly-
morphism and change in expression level, as
evident from published literature. Each record
contains details related to gene like architecture
(exon–intron structure), location, function, se-
quences (mRNA/CDS/protein), ontology, interacting
partners, homology to other eukaryotic genomes,
structure and links to other public databases, thus
augmenting CCDB with external data. Also,
manually curated literature references have been
provided to support the inclusion of the gene in
the database and establish its association with
cervix cancer. In addition, CCDB provides informa-
tion on microRNA altered in cervical cancer as well
as search facility for querying, several browse
options and an online tool for sequence similarity
search, thereby providing researchers with easy
access to the latest information on genes involved
in cervix cancer.
INTRODUCTION
Carcinoma of the uterine cervix is the most common ma-
lignancy that affects women in several parts of the world
and causes high mortality (1). It is the second most
common cancer affecting women worldwide and its occur-
rence has steadily increased in young women (2). It has
been documented that approximately 500000 new cases
and 274000 deaths occur each year due to this disease
(3). This disease is more prevalent among women of low
socioeconomic status and is a major health problem in
developing countries. In India, it has become the leading
cancer among women with an annual incidence of about
130000 cases and 70–75000 deaths (4). It has been estab-
lished that human papillomavirus (HPV) is an etiologic
agent for development of cervical cancer, yet it has been
observed that an infection caused by HPV alone is not a
sufﬁcient factor for causation of cervical cancer. Rather,
genetic and environmental factors that act in concord-
ance have been suggested to contribute to the induction
of cervical cancer. It is thought that other reasons
including changes in tumor suppressor genes, activation
of cellular proto-oncogenes, chromosomal alterations or
altered expression of several genes too are required for
tumorigenesis (5). As a result several investigators in
recent years have, by conducting small-scale (individual
gene) and high-throughput studies like microarray expres-
sion proﬁling (6), compared normal cervical cells with
premalignant and malignant cervical cells. This has
resulted in generation of enormous data and revelation
of hundreds of genes that are differentially expressed,
thus providing researchers important resources to poten-
tially explore the molecular mechanisms and identify
cervix-cancer-related genes. Despite presence of volu-
minous biomedical literature in Pubmed that provides
evidence for variety of genes implicated in cervical
cancer and women worldwide increasingly being affected
from this malignancy, to our knowledge no resource exists
that focuses on cervix cancer. Strikingly, a number of
databases have been published over the years that collect
information on several specialized cancers like Human
Lung Cancer Database (7), Prostate Gene Database (8),
Oral Cancer Gene Database (9) and Breast Cancer Gene
Database (10), but none of these databases exists for genes
involved in cervix cancer causation, one of the leading
cancers that affect women worldwide.
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to construct an integrated database termed Cervical
Cancer gene DataBase (CCDB) that catalogs the genes
known to be involved in cervical carcinogenesis as
evidenced from the biomedical literature. To gather and
uniformly present the available information on cervix
cancer genes, we have created a user-friendly interface in
the form of CCDB. The database integrates heterogeneous
data including basic gene and protein information,
manually curated literature references to support inclusion
of a gene in the database, the biological alteration, gene
ontology (GO) information, homologous sequences in
other eukaryotic genomes, interacting partners,
microRNA (miRNA) reported to be altered in cervical
carcinomas as compared with normal cervix, as well as
information and links of several external resources/data-
bases in order to help in retrieval of any other related
information. In addition, the database provides search
facility for querying the database and an online tool for
sequence similarity search. Overall, CCDB is a specialized,
ﬁrst of its kind value-added database that will enable the
exploration of relevant information for all experimentally
determined human cervix-cancer-related genes making it a
unique resource in the area of cervix cancer biology.
DATA COLLECTION AND CONTENT
For collection of genes playing role in causation of cervix
cancer we have extensively searched Pubmed database and
collected the relevant literature manually. After we
obtained the literature, we read through the full text of
each article to identify one or more genes involved in
disease process. Thereafter, information regarding the
type of molecular and genetic events (such as methylation,
gene ampliﬁcation, mutation, altered expression and poly-
morphism) responsible for occurrence of cervical cancer
disease as documented in the references was recorded
along with the tracking number (PMID). Also, we have
collected information about the location from which
sample was collected by their respective authors to
conduct the study. This information has been introduced
in the reference table. Once a non-redundant list of genes
was extracted from the literature further information re-
garding the gene was derived and has been integrated into
other tables. Overall, CCDB is divided into six tables: (i)
the gene detail table, which stores information necessary
for the conversion between different gene and protein
identiﬁers, using the Gene ID as primary key, (ii) the
homology table, which stores the orthology relationships
derived from Homologene database (11), (iii) the reference
table (detailed above), (iv) the GO table, (v) the sequence
table, which stores mRNA, CDS and protein location and
sequences and (vi) 3D protein structure information table
(Figure 1).
miRNAs are a family of small non-coding RNA mol-
ecules that downregulate the expression of their
protein-coding gene targets. The recent studies provide
evidences that multiple miRNAs have altered expression
in various human cancers, including cervical cancer. This
provides a good indication that knowledge of differential
expression of miRNA in cancer may have substantial
diagnostic and prognostic value and hence these are con-
sidered as an important resource for cancer research.
Therefore, we selected cervix-cancer-related miRNAs
with experimental information from the literature and
documented information regarding host gene that codes
for miRNA, its location, the target gene and its potential
role.
Once all the information was gathered we integrated
the data in MySQL, an object-relational Database
Management System (RDBMS), which works at the
backend and the web interface, was built in PHP.
Currently, we have collected 537 genes that are involved
in the different stages of cervical carcinogenesis. The in-
formation thus accumulated is expected to be critical for
both scientiﬁc researchers and clinicians to understand
and determine the molecular mechanism that causes
cervix cancer.
DATA ACCESS
The data in the CCDB can be easily accessed in a variety
of ways. Users can query the database by gene name, gene
ID or chromosome number, which results in display of
gene-centered information in a new page (Figure 2). The
main page for each gene provides the following informa-
tion (i) a schematic view of intron/exon structure, (ii)
general information including the gene name, gene id,
contig, location, OMIM id, unigene id, Ensembl id,
HPRD id, (iii) link to references that validate the
presence of this gene in cervical cancer, (iv) link to hom-
ologous gene entries, (v) link to mRNA/CDS/Protein
sequence details and (vi) link to other public databases,
e.g. HGNC and PharmaGKB. Clicking on HPRD link
leads to GO information, and homologene id link
provides the details of similar sequences (mRNA and
protein id) that are present in other eukaryotic genomes
along with multiple sequence alignment generated using
clustalX (12) in pdf format. Further, to know how a
gene is related to cervix cancer, the user can click on the
reference link that displays the references used as evidence
for establishing relationship of the gene to cervix cancer
along with the aberrant biological process responsible for
causing cervix cancer. Moreover, the mRNA/CDS/
Protein link provides information regarding the various
isoforms encoded by the gene, their location, length as
well as mRNA, CDS and protein sequences of each
isoform.
Also CCDB provides three other ways to view and
retrieve all cervix-cancer-related genes. First, a user can
query the database for human chromosome number to
display the genes present on each chromosome and then
browse them individually. Second, CCDB also offers a
browsing section, which allows the user to access the
entire collection of genes (complete list) or search the
genes by their names that are ordered in the alphabetical
mode. Finally, the genes have been categorized into bio-
logical process whose alteration leads to cervix cancer
disease as evident from literature. Thus, CCDB provides
a gateway through which the biomedical community can
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in cervix cancer.
Further, a customized BLAST (13) tool has been made
available that searches a user-deﬁned query against the
sequences available in the database. It may be useful in
characterization of orphan sequences and ﬁshing out of
homologous sequences from the database, based on
sequence similarity. Additionally, an online submission
facility has been provided to add gene entries that are
associated with cervix cancer (this option is yet to be func-
tional). Once the user adds new gene information with
speciﬁed ﬁelds (the ﬁelds with star are mandatory), the
database would be updated after validation.
DISCUSSION
Although over the years a large number of cancer-speciﬁc
databases (e.g. Human Lung Cancer Database, Prostate
Gene Database, Oral Cancer Gene Database and Breast
Cancer Gene Database) have been published, yet, to date
to our knowledge, there is no resource available that
provides detailed information about the genes known to
be associated with cervix cancer. Therefore we have
compiled the ﬁrst CCDB, where manual curation along
with information from other resources have been
integrated to provide a knowledgebase that will allow re-
searchers and clinicians to get an overview of biology of
the genes involved in cervix cancer. We hope that the
availability of this database would save time and effort
of researchers involved in the ﬁeld and thus will facilitate
the biological discovery process.
GO terms have been used previously to characterize
protein function and to elucidate trends in protein
datasets. We too classiﬁed all cervix-cancer-related genes
according to the molecular function of each protein and
the biological process in which it is involved. Assignment
of 537 genes to various molecular functions revealed that
the top ﬁve categories represented in the dataset are: tran-
scription factor activity, transcription regulatory activity,
cell adhesion molecule activity, receptor activity and DNA
binding, thereby suggesting importance of these gene
products for developmental pathway of cervical cancer
cells. Also, we observed that the biological processes
that are enriched in CCDB are (i) cell communication
and signal transduction pathway: 26%, (ii) regulation of
nucleobase, nucleoside, nucleotide and nucleic acid
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Figure 1. The database structure of CCDB.
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suggests that these biological processes may be involved in
transition of cell progression to cancerous state.
Further homology information is crucial as it reveals
how conserved a protein has remained through evolution,
and hence the degree to which it can tolerate alteration
within the sequence. Using the data of 537 genes involved
in cervix cancer we ﬁnd most of the proteins exhibit
homology to other eukaryotic genomes except six.
Although almost all the proteins exhibit homologous se-
quences in other genomes, majority (39%) are conserved
in Euteleostomi and only a small fraction are conserved in
eukaryotic crown group (16%), i.e. they are highly
conserved across the eukaryotic domain of life. The
presence of a large proportion of CCDB genes within
Euteleostomi group suggests that these genes are present
in ﬁsh species and have arisen recently on the evolutionary
line and thus, it may be possible that these proteins are
responsible for distinguished characteristics.
Also it is a well-established fact that hypermethylation
of tumor-suppressor genes has long been associated with
various cancers, including cervical cancer. In the present
version of CCDB, we present evidence for 69 genes that
are hypermethylated in cervical cancer, much more than
the PubMeth database (14). PubMeth is an annotated and
reviewed database of methylation in cancer, which
catalogs information for 36 genes involved in various
stages of cervical cancer. However, presently our
database is not supported by as many literature references
as documented in PubMeth. Therefore, we feel that our
database will complement the existing database in serving
scientiﬁc community.
Also, another advantage of this database will be that it
allows researchers to make a thorough comparison of
genes that are common in most of the cancers as well as
detect the ones that are unique and demonstrate aberrant
behavior in cervix cancer. For example, comparison of the
present set of CCDB genes with two other databases
(human lung cancer database and prostate gene
database) revealed that there are 293 and 35 genes
common among these cancers respectively.
CURRENT STATUS AND FUTURE DEVELOPMENTS
The current release (v. 1.0) of CCDB contains 537 unique
genes that are supported by evidence from unique Pubmed
Figure 2. Schematic workﬂow of CCDB.
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apart from search facility, several browsing options facili-
tate fast, efﬁcient and user-friendly retrieval of informa-
tion. We propose to update this database on a regular
basis adding new data from literature as well as other
data analysis tools that will help in improving our know-
ledge about cervix cancer and potentially contribute to the
development of novel therapeutic strategies. Since not all
genes published in literature are yet included in the current
release of the database, our foremost objective would be to
identify, collect and add those genes. Also, another limi-
tation of the present version is that not all the related
references for a given gene have been covered.
Therefore, in the next update we plan to add more litera-
ture references for genes in the current version. We also
propose to extend search facility and include information
about transcription factor binding site. Overall, we aim to
increase the quality of data and to supply additional
database function.
SUMMARY
In summary, CCDB is a ﬁrst attempt to provide a com-
prehensive non-redundant catalog of genes involved in the
cervix cancer along with information about the altered
biological process and supporting evidence from published
literature. It is expected that availability and use of CCDB
will reduce the time and effort of scientists and clinicians
to survey the literature on genes and their involvement in
cervix diseases. It thus provides a unique value-added
resource in the ﬁeld of cervix cancer biology.
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